IndraLab

Statements


Mutated MDM2 inhibits TP53. 10 / 10
| 10

reach
"In agreement with this model, mdm2 mutants defective in p300 but not in p53 binding failed to mediate degradation of p53 and a p53 mutant unable to bind to the N-terminal E6 like domain of p300 was re[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"Moreover, the RPL11 haploinsufficiency–induced p53 activation was prevented by the MDM2 mutation at both protein (Fig. 6E) and mRNA (Fig. 6, F and G) levels."

reach
"In contrast, the MDM2 mutants that enhance p53 degradation (W335L, S435R, M465I) would promote tumor development by maintaining p53 at low levels."

reach
"In the absence of antagonist, p53 function was reduced ~ 90% by wild-type and mutant HDM2."

reach
"The mutant MDM2 proteins were unable to inhibit p53 dependent transcription in vivo, which is consistent with prior indications that a physical interaction between the two proteins is required for MDM2 's inhibition of p53."

reach
"These results established the unique properties of the E2-binding mutant MDM2 that genetically separate MDM2-MDM4 E3 ligase activity from MDM2-MDM4 mediated suppression of p53 transcriptional transactivation."

reach
"As shown in Fig. 5 , overexpression of wild-type MDM2 reduced the protein level of TCAP and p53, but the reduction for TCAP did not appear to require the C-terminal RING finger domain of MDM2, as the [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"Thus, it was found that an Mdm2 mutant lacking residues 222-272 also fails to drive p53 degradation, and actually promotes p53 stabilization [88]."

reach
"In contrast, the MDM2 mutants that failed to degrade p53 in our degradation assays generated fewer and smaller colonies than the wild-type MDM2 stable cells."

reach
"Importantly, the Deltap1-23A Mdm2 mutant interacts with p53 similarly to wild-type Mdm2 (XREF_SUPPLEMENTARY) and degrades p53 as efficiently as wild-type Mdm2 (XREF_SUPPLEMENTARY)."